Vor Biopharma Inc. (VOR)
1.38
0.04 (2.99%)
At close: Jan 15, 2025, 2:34 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -117.86M | -92.09M | -68.90M | -43.34M | -10.84M | -4.15M |
| Depreciation & Amortization | 3.49M | 2.52M | 1.43M | 605.00K | 91.00K | 20.00K |
| Stock-Based Compensation | 13.36M | 10.70M | 4.32M | 1.34M | 172.00K | 116.00K |
| Other Working Capital | -2.20M | -12.69M | -9.59M | -1.50M | -1.07M | 63.00K |
| Other Non-Cash Items | 67.00K | 6.42M | 3.19M | 782.00K | 608.00K | 1.00M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | -32.00K | 289.00K |
| Change in Working Capital | 650.00K | -12.69M | -9.19M | 4.32M | 145.00K | 63.00K |
| Operating Cash Flow | -100.29M | -85.14M | -69.14M | -36.29M | -9.86M | -2.66M |
| Capital Expenditures | -1.07M | -8.46M | -3.89M | -4.16M | -748.00K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -74.92M | -123.19M | -87.76M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 147.00M | 37.56M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -0.00 | -87.76K | n/a | n/a | n/a |
| Investing Cash Flow | 71.01M | -94.09M | -91.65M | -4.16M | -748.00K | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | 2.46M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -1.64M | 1.17M | 43.71M | 82.53M | 17.70M | n/a |
| Financial Cash Flow | 2.94M | 117.14M | 232.91M | 82.53M | 17.70M | 2.46M |
| Net Cash Flow | -26.35M | -62.09M | 72.12M | 42.07M | 7.10M | -197.00K |
| Free Cash Flow | -101.36M | -93.61M | -73.04M | -40.45M | -10.60M | -2.66M |